These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12699706)

  • 21. Prions and their partners in crime.
    Caughey B; Baron GS
    Nature; 2006 Oct; 443(7113):803-10. PubMed ID: 17051207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cellular prion protein on blood cells: potential functions in cell physiology and pathophysiology of transmissible spongiform encephalopathy diseases.
    Vostal JG; Holada K; Simak J
    Transfus Med Rev; 2001 Oct; 15(4):268-81. PubMed ID: 11668434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prions and manganese: A maddening beast.
    Brown DR
    Metallomics; 2011 Mar; 3(3):229-38. PubMed ID: 21390367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free radical generation of protease-resistant prion after substitution of manganese for copper in bovine brain homogenate.
    Deloncle R; Guillard O; Bind JL; Delaval J; Fleury N; Mauco G; Lesage G
    Neurotoxicology; 2006 May; 27(3):437-44. PubMed ID: 16481041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of prion protein expression on metal metabolism.
    Kralovicova S; Fontaine SN; Alderton A; Alderman J; Ragnarsdottir KV; Collins SJ; Brown DR
    Mol Cell Neurosci; 2009 Jun; 41(2):135-47. PubMed ID: 19233277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prions at the crossroads: the need to identify the active TSE agent.
    Nandi PK
    Bioessays; 2004 May; 26(5):469-73. PubMed ID: 15112226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
    Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
    J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of dietary manganese and copper imbalance on neuronal apoptosis in a murine model of scrapie.
    Bolea R; Hortells P; Martín-Burriel I; Vargas A; Ryffel B; Monzón M; Badiola JJ
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):300-11. PubMed ID: 20070537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metals in obex and retropharyngeal lymph nodes of Illinois white-tailed deer and their variations associated with CWD status.
    Rivera NA; Novakofski J; Weng HY; Kelly A; Satterthwaite-Phillips D; Ruiz MO; Mateus-Pinilla N
    Prion; 2015; 9(1):48-58. PubMed ID: 25695915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prion diseases: pathogenesis and public health concerns.
    Dormont D
    FEBS Lett; 2002 Oct; 529(1):17-21. PubMed ID: 12354606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.
    Martin DP; Anantharam V; Jin H; Witte T; Houk R; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2011 Oct; 32(5):554-62. PubMed ID: 21871919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human transmissible spongiform encephalopathies: historic view.
    Asher DM; Gregori L
    Handb Clin Neurol; 2018; 153():1-17. PubMed ID: 29887130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concluding remarks.
    Pocchiari M; Manson J
    Handb Clin Neurol; 2018; 153():485-488. PubMed ID: 29887155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
    Bastian FO; Fermin CD
    Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular clues to pathogenesis in prion diseases.
    Laurent M; Johannin G
    Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing transmissible spongiform encephalopathy species barriers with an in vitro prion protein conversion assay.
    Johnson CJ; Carlson CM; Morawski AR; Manthei A; Cashman NR
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.